阿迪波金在内皮细胞功能中的多面性作用
Yu Yan1, Lihui Wang2, Ni Zhong3
1School of Exercise and Health, Shanghai University of Sport, Shanghai, China.
Frontiers in endocrinology
|November 19, 2024
概括
肥胖会通过动脉样硬化恶化心血管疾病 (CVD). 本综述详细介绍了脂肪分泌分子阿迪波金如何影响内皮功能,为心血管疾病治疗提供了点.
科学领域:
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
- 分子生物学分子生物学
背景情况:
- 肥胖是心血管疾病 (CVD) 和死亡率的主要风险因素.
- 动脉样硬化,一个关键的心血管疾病过程,始于血管内皮功能障碍.
- 由脂肪组织分泌的阿迪波基因,极大地影响内皮功能.
研究的目的:
- 综合审查各种阿迪波金在动脉样硬化期间内皮功能中的作用.
- 在这种情况下,将阿迪波金类别分为保护性或有害性.
- 探索用于动脉样硬化治疗的阿迪波金向策略.
主要方法:
- 关于阿迪波金和内皮功能的科学研究的文献综述.
- 根据其对血管内皮的作用对阿迪波金的分类.
- 对将阿迪波金与动脉样硬化联系起来的致病机制的分析.
主要成果:
- 阿迪波金可显著调节动脉样硬化中的内皮功能.
- 保护性阿迪波金包括阿迪波涅丁,FGF21,CTRP9,PGRN,奥门丁和瓦斯.
- 有害的阿迪波金包括勒素,凯美林,抵抗素和FABP4.
结论:
- 阿迪波金在调节动脉样硬化中的内皮功能方面发挥着双重作用.
- 针对特定的阿迪波金是一种有希望的治疗途径,用于与动脉样硬化相关的心血管疾病.
- 本综述为开发新型心血管疾病治疗提供了理论基础.
更多相关视频
09:00Isolation and Identification of Vascular Endothelial Cells from Distinct Adipose Depots for Downstream Applications
Published on: June 10, 2022
2.7K
06:35Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies
Published on: April 5, 2024
889
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Lipid-derived Compounds in the Human Body
4.3K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.3K
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
Overview of the Vascular System
2.7K
The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
2.7K
Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Adrenergic Receptors: ɑ Subtype
1.4K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.4K
